SNRPB is the B protein subunit of the U1 and U2 snRNPs, essential for spliceosome assembly and pre-mRNA splicing in the major spliceosome pathway.
Function
The SNRPB gene encodes a protein involved in RNA processing and splicing mechanisms critical for neuronal function and survival.
Role in RNA Processing
SNRPB participates in the spliceosome-mediated removal of introns from pre-mRNA. Dysregulation of splicing factors has been implicated in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and spinal muscular atrophy (SMA). The spliceosome, a large ribonucleoprotein complex, undergoes dynamic conformational changes during the splicing cycle, and SNRPB contributes to splice site recognition and catalytic steps.
Neurological Relevance
Alterations in RNA splicing are a hallmark of many neurodegenerative disorders. Mutations in genes encoding splicing factors can lead to aberrant splicing patterns that affect neuronal viability. The SNRPB protein is expressed in various brain regions, including the [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and spinal cord, where it supports proper RNA metabolism essential for neuronal health.
Disease Associations
| Disease | Relationship | Evidence | |---------|--------------|----------| | Amyotrophic Lateral Sclerosis (ALS) | Dysregulated splicing | Altered expression in ALS motor [neurons](/entities/neurons) | | Frontotemporal Dementia (FTD) | Splicing abnormalities | Found in inclusion bodies in FTD | | Spinal Muscular Atrophy (SMA) | Spliceosome dysfunction | Part of the SMN complex regulation |
Inheritance Patterns
ALS/FTD: Typically sporadic, with rare familial cases linked to specific mutations
SMA: Autosomal recessive inheritance due to SMN1 deletion
Expression
SNRPB is expressed ubiquitously in human tissues, with high expression in:
Brain (cerebral cortex, hippocampus, cerebellum)
Spinal cord
Skeletal muscle
Heart
Therapeutic Implications
Targeting splicing modulation represents a therapeutic strategy for neurodegenerative diseases. Small molecule splicing modulators are being developed to restore proper splicing patterns. The SNRPB protein may serve as a biomarker for spliceosome dysfunction in neurodegeneration.